CIPLA : USFDA CLASSIFIES GOA PLANT INSPECTION AS VAI ✅💊

• 🇺🇸 USFDA has classified the inspection at Cipla's Verna, Goa manufacturing facility as Voluntary Action Indicated (VAI) • 🏭 The inspection included a routine cGMP inspection and a Pre-Approval Inspection (PAI) conducted between April 6–17, 2026 • 📩 Cipla received the USFDA classification communication on June 10, 2026 • ✅ VAI status means the regulator observed certain issues but no regulatory or enforcement action is currently warranted • 🌎 The outcome supports continued operations and product supplies from the facility to regulated markets 🟢 Impact: Positive (Removes regulatory uncertainty, supports approvals pipeline and reinforces compliance standards at a key manufacturing facility.)

CIPLA LTD

← Back to feed